Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-Linac

NCT04172753 · tracked via the Priya Life Science Germany tracker

Sponsor

University Hospital Tuebingen

Phase

Not applicable

Started

2018-05-09

Last updated

2019-11-21

Condition(s) studied

Rectal CancerHead and Neck CancerLiver CancerBreast CancerProstate CancerOligometastasisEsophageal Cancer

Investigational drug(s) / intervention(s)

Radiotherapy on the MR-LinacImaging on the MR Linac

Radiotherapy on the MR-Linac: Radiotherapy is performed on the 1.5 T MR Linac

Imaging on the MR Linac: Only imaging performed on the MR Linac

Study summary

This study investigates the feasibility of imaging and treatment on a novel 1.5 T MR-Linac radiotherapy hybrid device.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * existing indication for radiation therapy * minimum age 18 years, no upper age limit * capacity for consent * Informed consent Exclusion Criteria: * contraindication for MRI (claustrophobia, metallic implants not applicable for MRI * pregnancy

Primary outcome measure(s)

Feasibility of online MR guided Radiotherapy — During every single patients treatment (i.e. between one to seven weeks after the first application of radiotherapy)
Treatment of a patient is considered feasible when 85% of treatments were completed as planned in this patient

Trial sites (1)

Facility	City	Region	Status
University Hospital Tübingen, Department of Radiation Oncology	Tübingen	Baden-Wurttemberg	Recruiting

More University Hospital Tuebingen trials in Germany

A Strong Start in Life - ELAS 2.0: A Digital Learning Program to Promote a Healthy Pregnancy and Early Child Protection Starting soon

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults Recruiting

PREG - Offspring: Investigation of Children From Mothers With and Without Gestational Diabetes Recruiting

The preSPG4 Study - Studying the Prodromal and Early Phase of SPG4 Recruiting

Enhancing Brain Health by TDCS in Persons with Overweight and Obesity Active, not recruiting

Other trials for the same condition

A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02) Active, not recruiting

Early Prostate Cancer Recurrence With PSMA PET Positive Unilateral Pelvic Lesion(s) Recruiting

Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer Active, not recruiting

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment. Recruiting

A Study of Tumor Imaging With Multispectral Optoacoustic Tomography Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04172753 on ClinicalTrials.gov ↗ ← All trials in Germany